Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Epigenetic reprogramming of breast cancer cells with oocyte extracts.

Allegrucci C, Rushton MD, Dixon JE, Sottile V, Shah M, Kumari R, Watson S, Alberio R, Johnson AD.

Mol Cancer. 2011 Jan 13;10(1):7. doi: 10.1186/1476-4598-10-7.

2.

Epigenetic reprogramming of human lung cancer cells with the extract of bovine parthenogenetic oocytes.

Wang Z, Dao R, Bao L, Dong Y, Wang H, Han P, Yue Y, Yu H.

J Cell Mol Med. 2014 Sep;18(9):1807-15. doi: 10.1111/jcmm.12306. Epub 2014 May 30.

3.

Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.

Wang Z, Yue Y, Han P, Sa R, Ren X, Wang J, Bai H, Yu H.

Cytotherapy. 2013 Sep;15(9):1164-73. doi: 10.1016/j.jcyt.2013.05.001. Epub 2013 Jun 22.

PMID:
23800731
4.

Epigenetic marks in somatic chromatin are remodelled to resemble pluripotent nuclei by amphibian oocyte extracts.

Bian Y, Alberio R, Allegrucci C, Campbell KH, Johnson AD.

Epigenetics. 2009 Apr 1;4(3):194-202. Epub 2009 Apr 16.

PMID:
19440040
5.

Cancer reversion with oocyte extracts is mediated by cell cycle arrest and induction of tumour dormancy.

Saad N, Alberio R, Johnson AD, Emes RD, Giles TC, Clarke P, Grabowska AM, Allegrucci C.

Oncotarget. 2018 Mar 23;9(22):16008-16027. doi: 10.18632/oncotarget.24664. eCollection 2018 Mar 23.

6.

Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation.

Montenegro MF, Sáez-Ayala M, Piñero-Madrona A, Cabezas-Herrera J, Rodríguez-López JN.

PLoS One. 2012;7(12):e52231. doi: 10.1371/journal.pone.0052231. Epub 2012 Dec 14.

7.

Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.

Kar S, Patra SK.

Gene. 2018 Feb 15;643:35-45. doi: 10.1016/j.gene.2017.11.077. Epub 2017 Dec 1.

PMID:
29203199
8.

ITIH5 mediates epigenetic reprogramming of breast cancer cells.

Rose M, Kloten V, Noetzel E, Gola L, Ehling J, Heide T, Meurer SK, Gaiko-Shcherbak A, Sechi AS, Huth S, Weiskirchen R, Klaas O, Antonopoulos W, Lin Q, Wagner W, Veeck J, Gremse F, Steitz J, Knüchel R, Dahl E.

Mol Cancer. 2017 Feb 23;16(1):44. doi: 10.1186/s12943-017-0610-2.

9.

Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, Lacaze P, Kaplan W, Robinson MD, Clark SJ.

Nat Cell Biol. 2010 Mar;12(3):235-46. doi: 10.1038/ncb2023. Epub 2010 Feb 21.

10.

Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.

da Costa Prando E, Cavalli LR, Rainho CA.

Epigenetics. 2011 Dec;6(12):1413-24. doi: 10.4161/epi.6.12.18271.

11.

Cell-free extracts from mammalian oocytes partially induce nuclear reprogramming in somatic cells.

Miyamoto K, Tsukiyama T, Yang Y, Li N, Minami N, Yamada M, Imai H.

Biol Reprod. 2009 May;80(5):935-43. doi: 10.1095/biolreprod.108.073676. Epub 2009 Jan 21.

PMID:
19164171
12.

Gene Resistance to Transcriptional Reprogramming following Nuclear Transfer Is Directly Mediated by Multiple Chromatin-Repressive Pathways.

Jullien J, Vodnala M, Pasque V, Oikawa M, Miyamoto K, Allen G, David SA, Brochard V, Wang S, Bradshaw C, Koseki H, Sartorelli V, Beaujean N, Gurdon J.

Mol Cell. 2017 Mar 2;65(5):873-884.e8. doi: 10.1016/j.molcel.2017.01.030.

13.

Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.

Farthing CR, Ficz G, Ng RK, Chan CF, Andrews S, Dean W, Hemberger M, Reik W.

PLoS Genet. 2008 Jun 27;4(6):e1000116. doi: 10.1371/journal.pgen.1000116.

14.

Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.

Wang Z, Gao H, Wang H, Ren X, Bao L, Sa R, Wang J, Bai H, Yu H.

Oncol Rep. 2013 Jul;30(1):179-84. doi: 10.3892/or.2013.2449. Epub 2013 May 10.

PMID:
23670097
15.

Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.

Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ.

PLoS Pathog. 2009 Jun;5(6):e1000492. doi: 10.1371/journal.ppat.1000492. Epub 2009 Jun 26.

16.

JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.

Kochat V, Equbal Z, Baligar P, Kumar V, Srivastava M, Mukhopadhyay A.

PLoS One. 2017 Mar 22;12(3):e0173977. doi: 10.1371/journal.pone.0173977. eCollection 2017.

17.

Evaluation in mammalian oocytes of gene transcripts linked to epigenetic reprogramming.

Oliveri RS, Kalisz M, Schjerling CK, Andersen CY, Borup R, Byskov AG.

Reproduction. 2007 Oct;134(4):549-58.

18.

Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.

Borges S, Döppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, Thompson E, Geiger XJ, Storz P.

Breast Cancer Res. 2013 Aug 23;15(2):R66. doi: 10.1186/bcr3460.

19.

Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.

Hinshelwood RA, Huschtscha LI, Melki J, Stirzaker C, Abdipranoto A, Vissel B, Ravasi T, Wells CA, Hume DA, Reddel RR, Clark SJ.

Cancer Res. 2007 Dec 15;67(24):11517-27.

20.

Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells.

Mu X, Sultankulov B, Agarwal R, Mahjoub A, Schott T, Greco N, Huard J, Weiss K.

Clin Orthop Relat Res. 2014 Mar;472(3):865-73. doi: 10.1007/s11999-013-3104-6.

Supplemental Content

Support Center